EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS
Antonio Del Casale
; Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant’Andrea Hospital, Rome, Italy, Department of Psychiatric Rehabilitation, San Francesco Institute, P. A
Georgios D. Kotzalidis
; Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant’Andrea Hospital, Rome, Italy
Michele Sacco
; Department of Psychiatric Rehabilitation, San Francesco Institute, P. Alberto Mileno Onlus Foundation, Vasto, CH, Italy, Center for Outcomes Research and clinical Epidemiology (CORESEARCH), Pescara, Italy
Chiara Rapinesi
; Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant’Andrea Hospital, Rome, Italy
Riccardo De Giorgi
; Department of Pathology, Foundation Year 2, Aberdeen Royal Infirmary (NHS Grampian), United Kingdom
Marco Giardini
; Department of Psychiatric Rehabilitation, San Francesco Institute, P. Alberto Mileno Onlus Foundation, Vasto, CH, Italy
Michele D’Andreagiovanni
; Department of Psychiatric Rehabilitation, San Francesco Institute, P. Alberto Mileno Onlus Foundation, Vasto, CH, Italy
Nicola Carlino
; Department of Psychiatric Rehabilitation, San Francesco Institute, P. Alberto Mileno Onlus Foundation, Vasto, CH, Italy
Roberto Brugnoli
; Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant’Andrea Hospital, Rome, Italy
Paolo Girardi
; Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant’Andrea Hospital, Rome, Italy
APA 6th Edition Del Casale, A., Kotzalidis, G.D., Sacco, M., Rapinesi, C., De Giorgi, R., Giardini, M., ... Girardi, P. (2016). EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS. Psychiatria Danubina, 28 (1), 0-94. Preuzeto s https://hrcak.srce.hr/154783
MLA 8th Edition Del Casale, Antonio, et al. "EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS." Psychiatria Danubina, vol. 28, br. 1, 2016, str. 0-94. https://hrcak.srce.hr/154783. Citirano 27.01.2021.
Chicago 17th Edition Del Casale, Antonio, Georgios D. Kotzalidis, Michele Sacco, Chiara Rapinesi, Riccardo De Giorgi, Marco Giardini, Michele D’Andreagiovanni, Nicola Carlino, Roberto Brugnoli i Paolo Girardi. "EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS." Psychiatria Danubina 28, br. 1 (2016): 0-94. https://hrcak.srce.hr/154783
Harvard Del Casale, A., et al. (2016). 'EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS', Psychiatria Danubina, 28(1), str. 0-94. Preuzeto s: https://hrcak.srce.hr/154783 (Datum pristupa: 27.01.2021.)
Vancouver Del Casale A, Kotzalidis GD, Sacco M, Rapinesi C, De Giorgi R, Giardini M i sur. EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS. Psychiatria Danubina [Internet]. 2016 [pristupljeno 27.01.2021.];28(1):0-94. Dostupno na: https://hrcak.srce.hr/154783
IEEE A. Del Casale, et al., "EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS", Psychiatria Danubina, vol.28, br. 1, str. 0-94, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/154783. [Citirano: 27.01.2021.]